Miltenyi biotec INC:1109450 [19-001883]
Ended Purchase Order Awarded Last action
- Contract number
- 75N90019P00095
- Awardee
-
Miltenyi Biotec, Inc. UEI ZLDPMHA3M333
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $51,338
Award facts
- Contract value 100% obligated
- $51,337.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,744 | |
| Funding Only Action | -$4,009 | |
| Exercise an Option | $28,965 | |
| Original award | $28,125 |
About this award
This federal contract award represents a de-obligation action by the NIH Clinical Center for Miltenyi Biotec, Inc., a specialized biotechnology manufacturer headquartered in Auburn, California. The purchase order, valued at $51,337.60 with an award date of December 7, 2018, was administratively de-obligated to remove unexpended and expiring fiscal year 2021 funding in accordance with federal requirements governing the closure of appropriated funds on September 30, 2026. The action reflects standard government fiscal management procedures for funds that were not obligated or expended during their period of availability. No set-aside designation was used in this procurement.
Miltenyi Biotec serves as a critical supplier to the NIH Clinical Center and other federal agencies, providing specialized cell separation, analysis, and processing equipment and proprietary reagents essential to biomedical research and cell therapy development. The company's product portfolio includes CliniMACS cell isolation microbeads, flow cytometry systems, and cell processing platforms that support Good Manufacturing Practice-compliant manufacturing of investigational cell therapy products used in FDA-regulated clinical trials. The vendor maintains an extensive relationship with the federal government through an indefinite delivery contract with the NIH Clinical Center valued at $4.6 million, which serves as the primary vehicle for procuring CliniMACS consumables and reagents that directly support over 50 intramural clinical trials focused on advancing cutting-edge cell therapy research and clinical care.
Quick answers
Who was awarded contract 75N90019P00095?
75N90019P00095 was awarded to Miltenyi Biotec, Inc. by NIH Clinical Center (National Institutes of Health) on December 7, 2018.
How much is contract 75N90019P00095 worth?
The government has obligated $51,338 on 75N90019P00095.
Was contract 75N90019P00095 competed?
The extent of competition for 75N90019P00095 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award